Use and perception of hormone therapy following media reports of the Women's Health Initiative: A survey of Australian WISDOM participants

Climacteric

Volumn 7, Issue 2, 2004, Pages 143-152

  Paine, B J ^a   Stocks, N P ^a   Ramsay, E N ^a   Ryan, P ^a   MacLennan, A H ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

Hormone therapy; Media; Perception; Wisdom; Women's health initiative

Indexed keywords

ESTROGEN; GESTAGEN;

ADULT; AGED; AUSTRALIA; AWARENESS; BREAST CANCER; CANCER RISK; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DRUG SAFETY; DRUG USE; FEMALE; FRACTURE; HEALTH SURVEY; HORMONAL THERAPY; HUMAN; INFORMATION; INFORMED CONSENT; MASS MEDIUM; MEDICAL RESEARCH; NORMAL HUMAN; PATIENT ATTITUDE; PHYSICIAN; PRIORITY JOURNAL; QUESTIONNAIRE; RATING SCALE; REVIEW; RISK FACTOR;

ADULT; AGED; ATTITUDE TO HEALTH; COMMUNICATIONS MEDIA; ESTROGEN REPLACEMENT THERAPY; FEMALE; HEALTHY PEOPLE PROGRAMS; HUMANS; MIDDLE AGED; PATIENT SELECTION; QUESTIONNAIRES; RANDOMIZED CONTROLLED TRIALS; SOUTH AUSTRALIA; WOMEN'S HEALTH;

EID: 3242715654     PISSN: 13697137     EISSN: None     Source Type: Journal    
DOI: 10.1080/13697130410001713742     Document Type: Review

References (19)

1. MacLennan AH, Henry D, Hill S, Moore V. Oral hormone replacement therapy for general menopausal symptoms (Protocol for a Cochrane Review). In The Cochrane Library, Issue 3, 1999. Oxford: Update Software
2. The Writing Group for the PEPI Trial. Effects of hormone therapy on bone mineral density. J Am Med Assoc 1996;276:1389-96
3. Barrett-Connor E, Grady D. Hormone replacement therapy, heart disease and other considerations. Annu Rev Public Health 1998;19:55-72
4. Henderson VW. The epidemiology of estrogen replacement therapy and Alzheimer's disease. Neurology 1997;48:S27-S35
5. Grodstein F, Newcomb PA, Stampfer MJ. Postmenopausal hormone therapy and the risk of colorectal cancer: a review and meta-analysis. Am J Med 1999;106:574-82
6. Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52 705 women with breast cancer and 108 411 women without breast cancer. Lancet 1997;350:1047-59
7. Vickers MR, Meade TW, Wilkes HC. Hormone replacement therapy and cardiovascular disease: the case for a randomized controlled trial. Ciba Found Symp 1995;191:150-60
8. The Women's Health Initiative Study Group. Design of the Women's Health Initiative clinical trial and observational study. Control Clin Trials 1998;19:61-109
9. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women - principal results from the Women's Health Initiative randomized controlled trial. J Am Med Assoc 2002;288:321-33
10. Manson JE, Hsia J, Johnson KC, et al. Estrogen plus progestogen and the risk of coronary heart disease. N Engl J Med 2003;349:523-34
11. Vickers M, Meade T, Darbyshire J. WISDOM: history and early demise - was it inevitable? Climacteric 2002;5:317-25
12. Chan J. Response-order effects in Likert-type scales. Educational and Psychological Measurement 1991;51:531-40
13. Ettinger B, Grady D, Tosteson AN, Pressman A, Macer JL. Effect of the Women's Health Initiative on women's decisions to discontinue postmenopausal hormone therapy. Obstet Gynecol 2003;102:1225-32
14. One year after WHI reports, majority of women still confused and misinformed about the safety of menopausal hormone therapy. New York: Thursday, November 6, 2003 (NWHRC)
15. Breslau ES, Davis WW, Doner L, et al. The hormone therapy dilemma: women respond. J Am Med Womens Assoc 2003;58:33-43
16. Creasman WT, Hoel D, DiSaia PJ. WHI: Now that the dust has settled: a commentary. Am J Obstet Gynecol 2003;189:621-6
17. Shapiro S. Risks of estrogen plus progestin therapy: a sensitivity analysis of findings in the Women's Health Initiative randomized controlled trial. Climacteric 2003;6:302-10
18. Rehm J, Room R, Graham K, Monteiro M, Gmel G, Sempos CT. The relationship of average volume of alcohol consumption and patterns of drinking to burden of disease: an overview. Addiction 2003;98:1209-28
19. Wrensch M, Chew T, Farren G, et al. Risk factors for breast cancer in a population with high incidence rates. Breast Cancer Res 2003;5:R88-102